Senior Global Compound Market Access Leader, Immunology (Atopic Dermatitis/Respiratory)

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:

Market Access

Job Sub Function:

Health Economics Market Access

Job Category:

People Leader

All Job Posting Locations:

Horsham, Pennsylvania, United States of America

Job Description:

Senior Global Compound Market Access Leader, Immunology (Atopic Dermatitis/Respiratory)

About Immunology

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Our Immunology team leads in the development of transformational medicines for immunological disorders and illnesses. You can influence where medicine is going by restoring health to millions of people living with immune diseases. 

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

 Job Description

Global Commercial Strategy Organization, a group within Janssen Global Services and a member of Johnson & Johnson's family of companies, is recruiting for a Global Sr. Compound Market Access Leader. This position will be based in Horsham, PA.

The Senior Global Compound Market Access Leader (Sr. CMAL), reporting to the Vice President (VP), Global Market Access, Immunology has the key leadership role of developing and driving the Market Access strategy for the Atopic Dermatitis / Respiratory Disease Area (DAS) and potentially other new areas within the J&J Immunology portfolio. The Sr. CMAL provides strategic market access leadership at the disease areas portfolio level, expertly representing market access within the DAS leadership team, Compound Development Teams and other global strategy teams, building strong relationships and effective collaboration within the matrix. In doing so, the Sr. CMAL will shape key strategic decisions through input/contributions to Clinical Development and Integrated Evidence Generation Plans to ensure that strategic plans fully meet the needs of market access in key countries. The Sr. CMAL takes ownership in overseeing and driving Compound Market Access strategies in alignment with overall DAS strategies to support timely, optimal reimbursement in a highly challenging environment across diverse regions with complex and differing needs. The Sr. CMAL must understand the needs of markets and develop appropriate solutions. The Sr. CMAL will be leading a team Compound Market Access Leaders working on specific brands.

Key deliverables in details:

Lead the global market access strategy for the Atopic Dermatitis/Respiratory portfolio:

• Drive a portfolio Market Access strategies and own it together with key partners in regions and expert functions. Define across portfolio strategy enablers and implement them.
• Oversee for respective DAS the Compound Market Access Teams (CMAT), which include the core functions within Global Market Access (i.e., Health Economics, Patient Reported Outcomes [PRO], Access Policy, Pricing, Real-World Evidence & Analytics) to deliver the global market access strategy & key value communication tools for the brand.
• Serve as the leading resource on access strategies and is an active member of the global clinical and commercial product teams, as well as the disease area strategy groups.
• Be responsible for integrating pricing, payer research, health economic and epidemiology information to develop the optimal value strategy.
• Interact with Regional Market Access/Health Economics / Outcomes Research and Medical Affairs teams to coordinate and develop real world evidence generation in support of their access programs.
• Develop an integrated access strategy that reflects macro (health care reform, quality metrics, technology assessment) and disease specific (clinical profile, market segmentation, disease staging and clinical pathway) factors as well as the complexity of a companion diagnostic.
• Be responsible for ensuring that clinical development programs ful